After primary liver cancer is diagnosed in adults, tests are used primarily to determine whether the cancer has spread within the liver or to other parts of the body.
The process used to determine whether the cancer has spread within the liver or to other parts of the body is called staging.The information assembled during staging determines the stage of the disease.Determining the stage of the disease is important for the choice of treatment options.The following tests and items can be used for staging:
There are three ways that cancer can spread in the body.
Cancer can spread through the tissues, the lymphatic system, and the blood.
Cancer can spread from the primary site to other parts of the body.
When cancer cells spread to another part of the body, it is called metastasis.Cancer cells can leave the site of their growth (the primary tumor) and migrate to other sites through the lymphatic system or blood.
Metastases are the same type of tumor as the primary tumor.For example, if a primary liver cancer metastasizes to the lungs, the cancer cells in the lungs are actually liver cancer cells.The tumor is a metastatic liver cancer, not a lung cancer.
Many cancer deaths are caused by tumors that have metastasized from the primary site to other tissues or organs. This is called metastatic cancer.This animation shows how cancer cells metastasize from the primary site to other parts of the body.
The Barcelona Clinical Liver Cancer Staging System can be used to stage primary liver cancer in adults.
There are multiple staging systems for liver cancer.The Barcelona Clinical Liver Cancer Staging System (BCLC) is widely used, as described below.This system is used to predict patient prognosis and select treatment options based on:
The BCLC staging system is divided into 5 stages:
Treatment plans are based on the following staging groups.
BCLC stages 0, A, and B
The treatment of BCLC stages 0, A, and B is aimed at eradication.
Stages C and D of BCLC
Stages C and D of BCLC are treated to reduce symptoms caused by liver cancer and to improve the patient’s quality of life.Treatments have been difficult to cure liver cancer.